CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Koji Shinoda, Yasunobu Yoshikai

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'CD30 ligand could be a new therapeutic target for central nervous system autoimmunity'. Together they form a unique fingerprint.